BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12451240)

  • 1. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.
    Bühler LH; Spitzer TR; Sykes M; Sachs DH; Delmonico FL; Tolkoff-Rubin N; Saidman SL; Sackstein R; McAfee S; Dey B; Colby C; Cosimi AB
    Transplantation; 2002 Nov; 74(10):1405-9. PubMed ID: 12451240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates.
    Yamada Y; Ochiai T; Boskovic S; Nadazdin O; Oura T; Schoenfeld D; Cappetta K; Smith RN; Colvin RB; Madsen JC; Sachs DH; Benichou G; Cosimi AB; Kawai T
    Am J Transplant; 2014 Dec; 14(12):2704-12. PubMed ID: 25394378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.
    Leventhal J; Abecassis M; Miller J; Gallon L; Ravindra K; Tollerud DJ; King B; Elliott MJ; Herzig G; Herzig R; Ildstad ST
    Sci Transl Med; 2012 Mar; 4(124):124ra28. PubMed ID: 22399264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach.
    Sasaki H; Oura T; Spitzer TR; Chen YB; Madsen JC; Allan J; Sachs DH; Cosimi AB; Kawai T
    Hum Immunol; 2018 May; 79(5):258-265. PubMed ID: 29175110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic cell-based and non-hematopoietic cell-based strategies for immune tolerance induction in living-donor renal transplantation: A systematic review.
    Annamalai C; Kute V; Sheridan C; Halawa A
    Transplant Rev (Orlando); 2023 Dec; 37(4):100792. PubMed ID: 37709652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Mixed Lymphocyte Reaction Assay to Evaluate Immune Tolerance before Kidney Transplantation with an Immunosuppression-Free Protocol following Hematopoietic Stem Cell Transplantation from the Same Donor.
    Nonoyama S; Hotta K; Iwahara N; Tanabe T; Hirose T; Harada S; Junichi S; Nakazawa D; Shigematsu A; Otsuka T; Shinohara N
    Nephron; 2023; 147(10):621-626. PubMed ID: 37231903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient mixed chimerism for allograft tolerance.
    Oura T; Hotta K; Cosimi AB; Kawai T
    Chimerism; 2015 Apr; 6(1-2):21-6. PubMed ID: 26517761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune monitoring of transplant patients in transient mixed chimerism tolerance trials.
    Sykes M
    Hum Immunol; 2018 May; 79(5):334-342. PubMed ID: 29289741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helical TomoTherapy Total Lymphoid Irradiation and Hematopoietic Cell Transplantation for Kidney Transplant Tolerance in Rhesus Macaques.
    Kaufman DB; Forrest LJ; Fechner J; Post J; Coonen J; Haynes LD; Haynes WJ; Christensen N; Zhong W; Little CJ; D'Alessandro A; Fernandez L; Brunner K; Jensen K; Burlingham WJ; Hematti P; Strober S
    Transpl Int; 2023; 36():11279. PubMed ID: 37426429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Bone Marrow and Kidney Transplantation for the Induction of Specific Tolerance.
    Chen YB; Kawai T; Spitzer TR
    Adv Hematol; 2016; 2016():6471901. PubMed ID: 27239198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Immunocompetence and Biomarkers of Tolerance in Chimeric and Immunosuppression-free Kidney Allograft Recipients.
    Leventhal JR; Galvin J; Ison MG; Feng CY; Ding R; Lee JR; Li C; Mathew JM; Gallon L; Gibson M; Belshe D; Tollerud DJ; Gornstein E; Suthanthiran M; Ildstad ST
    Transplantation; 2023 Oct; 107(10):e257-e268. PubMed ID: 37370204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short Tandem Repeat Analysis in a Living Related Donor Adult Renal Transplant Recipient with Rare Natural Chimerism.
    Meng X; Yang B; Wu D; Pan T; Zhang F; Xie H; Xie W; Chen X; Zheng S
    Exp Clin Transplant; 2023 Nov; 21(11):917-920. PubMed ID: 38140935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male microchimerism at high levels in peripheral blood mononuclear cells from women with end stage renal disease before kidney transplantation.
    Albano L; Rak JM; Azzouz DF; Cassuto-Viguier E; Gugenheim J; Lambert NC
    PLoS One; 2012; 7(3):e32248. PubMed ID: 22403639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma and kidney transplantation: the beginning of a new era.
    Van den Bosch I; Sprangers B; Gertz M
    Clin Kidney J; 2019 Apr; 12(2):213-215. PubMed ID: 30976398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leveraging the lymphohematopoietic graft-versus-host reaction (LGVHR) to achieve allograft tolerance and restore self tolerance with minimal toxicity.
    Sykes M
    Immunother Adv; 2023; 3(1):ltad008. PubMed ID: 37426630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance protocol of living kidney transplant for developing countries through basic strategy of lymphocyte depletion.
    Suhail SM
    World J Transplant; 2022 Jun; 12(6):112-119. PubMed ID: 35979538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney Transplant Outcomes of Patients With Multiple Myeloma.
    Heybeli C; Bentall AJ; Alexander MP; Amer H; Buadi FK; Dispenzieri A; Dingli D; Gertz MA; Issa N; Kapoor P; Kukla A; Kumar S; Lorenz EC; Rajkumar SV; Schinstock CA; Leung N
    Kidney Int Rep; 2022 Apr; 7(4):752-762. PubMed ID: 35497786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically available immunosuppression averts rejection but not systemic inflammation after porcine islet xenotransplant in cynomolgus macaques.
    Graham ML; Ramachandran S; Singh A; Moore MEG; Flanagan EB; Azimzadeh A; Burlak C; Mueller KR; Martins K; Anazawa T; Appakalai BN; Bansal-Pakala P; Murtaugh MP; O'Brien TD; Papas KK; Spizzo T; Schuurman HJ; Hancock WW; Hering BJ
    Am J Transplant; 2022 Mar; 22(3):745-760. PubMed ID: 34704345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens.
    Rodriguez-Barbosa JI; Schneider P; Graca L; Bühler L; Perez-Simon JA; Del Rio ML
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation tolerance in nonhuman primates and humans.
    Sykes M; Griesemer AD
    Bone Marrow Transplant; 2019 Aug; 54(Suppl 2):815-821. PubMed ID: 31431694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.